Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch

Daisuke Aki, Qian Li, Hui Li, Yun‐Cai Liu, Jee Ho LeeProtein & Cell 2018 · DOI

Abstract

Protein ubiquitination is an important means of post-translational modification which plays an essential role in the regulation of various aspects of leukocyte development and function. The specificity of ubiquitin tagging to a protein substrate is determined by E3 ubiquitin ligases via defined E3-substrate interactions. In this review, we will focus on two E3 ligases, VHL and Itch, to discuss the latest progress in understanding their roles in the differentiation and function of CD4<sup>+</sup> T helper cell subsets, the stability of regulatory T cells, effector function of CD8<sup>+</sup> T cells, as well as the development and maturation of innate lymphoid cells. The biological implications of these E3 ubiquitin ligases will be highlighted in the context of normal and dysregulated immune responses including the control of homeostasis, inflammation, auto-immune responses and anti-tumor immunity. Further elucidation of the ubiquitin system in immune cells will help in the design of new therapeutic interventions for human immunological diseases and cancer.

Introduction: The Specificity of the Ubiquitin Code

The immune system operates as a high-stakes balancing act, requiring aggressive responses to clear pathogens and tumors while maintaining strict discipline to avoid autoimmunity. This regulation is largely governed by post-translational modifications, specifically ubiquitination—the tagging of proteins with a 76-amino acid polypeptide. While the general machinery of ubiquitination is well-characterized, the "specificity problem"—how a cell decides which protein to tag—is solved by E3 ubiquitin ligases. This review synthesizes a decade of research into how two specific ligases, VHL and Itch, act as molecular gatekeepers for immune homeostasis.

VHL: Linking Oxygen Sensing to Immune Metabolism

Von Hippel-Lindau (VHL) protein is a RING-type E3 ligase famous for its role as a tumor suppressor. Its primary function is to target Hypoxia-Inducible Factor 1α (HIF-1α) for degradation. In the immune system, this mechanism serves as a metabolic switch. Under normoxic conditions, VHL ensures HIF-1α levels remain low; however, when VHL is absent or oxygen is scarce, HIF-1α accumulates, driving cells into a glycolytic state.

Mechanism of VHL-mediated HIF-1α degradation under normoxia and its stabilization under hypoxia.

This metabolic reprogramming has profound effects on immune cell identity:

  • Regulatory T cells (Tregs): VHL loss destabilizes Tregs, causing them to produce pro-inflammatory cytokines like IFN-γ instead of suppressing inflammation.
  • CD8+ T cells: Deletion of VHL enhances the immediate cytotoxic killing ability of these cells against tumors but impairs their long-term memory formation.
  • Innate Lymphoid Cells (ILC2s): VHL is essential for maturation; its absence prevents the expression of the ST2 receptor, effectively stalling development.

Itch: The Signaling Brake of the T Cell

While VHL manages metabolic shifts, the HECT-type E3 ligase Itch acts as a negative regulator of T-cell receptor (TCR) signaling. Itch targets key signaling molecules like ZAP-70 and TCRζ for degradation. Without Itch, T cells become hyper-responsive, leading to the "itchy" mouse phenotype—characterized by spontaneous inflammation and massive IgE production.

Interestingly, Itch does not always work in isolation. It can cooperate with other ligases like WWP2 to target phosphatases such as SHP-1, which can actually enhance signaling in specific contexts. Furthermore, the combined loss of Itch and the ligase Cbl-b leads to a total breakdown of T-cell tolerance, resulting in rapid, lethal autoimmunity.

Methodological Approaches in Ubiquitin Research

To uncover these complex regulatory networks, researchers utilize several advanced methodologies:

  • Conditional Knockout (cKO) Mice: Using the Cre-Lox system to delete ligases in specific lineages (e.g., Vhl^fl/fl Lck-cre) to observe physiological defects in vivo.
  • Biochemical Interaction Assays: Mapping how E3 ligases recognize substrates via specific domains, such as the β-domain in VHL or WW domains in Itch.
  • UBAITs (Ubiquitin-Activated Interaction Traps): Identifying transient protein complexes between ligases and their targets.

Conclusion and Future Perspectives

Despite significant progress, the "ubiquitin code" remains a complex frontier. Challenges include understanding the functional redundancy among the NEDD4 family (to which Itch belongs) and mapping the specific types of ubiquitin linkages (e.g., K27 vs. K33) that determine whether a protein is degraded or activated. While these ligases are promising drug targets for cancer and autoimmunity, developing small molecules to specifically modulate E3-substrate interactions remains a significant therapeutic hurdle. Continued research into these molecular gatekeepers will be vital for designing next-generation interventions for immunological diseases.

Summary updated

Abstract

Protein ubiquitination is an important means of post-translational modification which plays an essential role in the regulation of various aspects of leukocyte development and function. The specificity of ubiquitin tagging to a protein substrate is determined by E3 ubiquitin ligases via defined E3-substrate interactions. In this review, we will focus on two E3 ligases, VHL and Itch, to discuss the latest progress in understanding their roles in the differentiation and function of CD4<sup>+</sup> T helper cell subsets, the stability of regulatory T cells, effector function of CD8<sup>+</sup> T cells, as well as the development and maturation of innate lymphoid cells. The biological implications of these E3 ubiquitin ligases will be highlighted in the context of normal and dysregulated immune responses including the control of homeostasis, inflammation, auto-immune responses and anti-tumor immunity. Further elucidation of the ubiquitin system in immune cells will help in the design of new therapeutic interventions for human immunological diseases and cancer.
BibTeX
@inproceedings{aki2018immune,
  author = {Daisuke Aki and Qian Li and Hui Li and Yun‐Cai Liu and Jee Ho Lee},
  title = {{Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch}},
  booktitle = {Protein \& Cell},
  year = {2018},
  doi = {10.1007/s13238-018-0586-8},
}
Figure